These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 32447934)

  • 1. [Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia].
    Zhang Y; Cao W; Xiao M; Li YJ; Yang Y; Zhao J; Zhou X; Jiang W; Zhao YQ; Zhang SY; Li TS
    Zhonghua Xue Ye Xue Za Zhi; 2020 Apr; 41(4):302-307. PubMed ID: 32447934
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia].
    Zhang Y; Cao W; Xiao M; Li YJ; Yang Y; Zhao J; Zhou X; Jiang W; Zhao YQ; Zhang SY; Li TS
    Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(0):E006. PubMed ID: 32220276
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.
    Tang N; Bai H; Chen X; Gong J; Li D; Sun Z
    J Thromb Haemost; 2020 May; 18(5):1094-1099. PubMed ID: 32220112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.
    Liao D; Zhou F; Luo L; Xu M; Wang H; Xia J; Gao Y; Cai L; Wang Z; Yin P; Wang Y; Tang L; Deng J; Mei H; Hu Y
    Lancet Haematol; 2020 Sep; 7(9):e671-e678. PubMed ID: 32659214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation abnormalities and thrombosis in patients with COVID-19.
    Levi M; Thachil J; Iba T; Levy JH
    Lancet Haematol; 2020 Jun; 7(6):e438-e440. PubMed ID: 32407672
    [No Abstract]   [Full Text] [Related]  

  • 6. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.
    Zhang Y; Cao W; Jiang W; Xiao M; Li Y; Tang N; Liu Z; Yan X; Zhao Y; Li T; Zhu T
    J Thromb Thrombolysis; 2020 Oct; 50(3):580-586. PubMed ID: 32648093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Embolism in Patients With Covid-19 Pneumonia: The Utility of D-dimer.
    Rodriguez-Sevilla JJ; Rodó-Pin A; Espallargas I; Villar-García J; Molina L; Pérez Terán P; Vázquez Sanchez A; Masclans JR; Jiménez C; Millan Segovia R; Zuccarino F; Salar A; Rodriguez-Chiaradía DA
    Arch Bronconeumol (Engl Ed); 2020 Nov; 56(11):758-759. PubMed ID: 32773301
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
    Miesbach W; Makris M
    Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review.
    Hayıroğlu Mİ; Çınar T; Tekkeşin Aİ
    Rev Assoc Med Bras (1992); 2020 Jun; 66(6):842-848. PubMed ID: 32696883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology.
    Chekkal M; Deba T; Hadjali S; Lamara H; Oulaa H; Zouai K; Hariti G
    Transfus Clin Biol; 2020 Nov; 27(4):203-206. PubMed ID: 33022374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2.
    Beun R; Kusadasi N; Sikma M; Westerink J; Huisman A
    Int J Lab Hematol; 2020 Jun; 42 Suppl 1(Suppl 1):19-20. PubMed ID: 32311843
    [No Abstract]   [Full Text] [Related]  

  • 12. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism and COVID-19.
    Bertoletti L; Couturaud F; Montani D; Parent F; Sanchez O
    Respir Med Res; 2020 Nov; 78():100759. PubMed ID: 32474397
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk Benefit Analysis in Reference to use of LMWH in COVID-19.
    Samajdar SS; Sam PA; Moitra S; Ray Y; Pal J; Joshi SR; Tripathi SK
    J Assoc Physicians India; 2020 Sep; 68(9):52-61. PubMed ID: 32798346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients.
    Ahmed SI; Khan S
    Curr Probl Cardiol; 2020 Sep; 45(9):100648. PubMed ID: 32703535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia.
    Costanzo L; Palumbo FP; Ardita G; Antignani PL; Arosio E; Failla G;
    J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):711-716. PubMed ID: 32561465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 coagulopathy: an evolving story.
    The Lancet Haematology
    Lancet Haematol; 2020 Jun; 7(6):e425. PubMed ID: 32470428
    [No Abstract]   [Full Text] [Related]  

  • 18. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.
    Tang N; Li D; Wang X; Sun Z
    J Thromb Haemost; 2020 Apr; 18(4):844-847. PubMed ID: 32073213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-dimer surge and coagulation disorders in COVID-19 related pneumonia patients with cardiac injury: A case series.
    Wang X; Du B; Li J; Wang S; Wang X; Guo M; Yang B; Si D; Bai O
    Medicine (Baltimore); 2020 Jul; 99(31):e21513. PubMed ID: 32756189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
    Hu X; Hu C; Yang Y; Chen J; Zhong P; Wen Y; Chen X
    Ther Adv Respir Dis; 2020; 14():1753466620963035. PubMed ID: 33138694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.